BDBM652465 5-N-[(6-{5H,6H,7H,8H-imidazo[1,2-a]pyridin-7-yloxy}pyridin-3-yl)methyl]isoquinoline- 1,5-diamine::US20240059691, Example 1049

SMILES Nc1nccc2c(NCc3ccc(OC4CCn5ccnc5C4)nc3)cccc12

InChI Key InChIKey=WZFGKOMTANPZBQ-UHFFFAOYSA-N

Data  2 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 2 hits for monomerid = 652465   

TargetCoagulation factor XII(Human)
Kalvista Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 652465BDBM652465(US20240059691, Example 1049 | 5-N-[(6-{5H,6H,7H,8H...)
Affinity DataIC50: 650nMAssay Description:In vitro inhibition of Factor XIIa was determined using an IC50 assay based on standard literature methods (see e.g Baeriswyl et al., ACS Chem. Biol....More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/24/2024
Entry Details
US Patent

TargetPlasma kallikrein(Human)
Kalvista Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 652465BDBM652465(US20240059691, Example 1049 | 5-N-[(6-{5H,6H,7H,8H...)
Affinity DataIC50: 7.00E+4nMAssay Description:In vitro inhibition of related proteases was determined using an (C50 assay based on standard literature methods (see e.g. Shori et al., Biochem. Pha...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/24/2024
Entry Details
US Patent